Literature DB >> 9370932

HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.

S Toda1, N Ishii, E Okada, K I Kusakabe, H Arai, K Hamajima, I Gorai, K Nishioka, K Okuda.   

Abstract

The adjuvant effect of mannan-coated liposomes on human immunodeficiency virus type-1 (HIV-1) DNA vaccine and the mechanism of this enhancement were studied. Coating of cationic liposomes with mannan significantly enhanced the ability of this vaccine to induce an HIV-specific delayed-type hypersensitivity (DTH) response. HIV-specific cytotoxic T-cell (CTL) activity elicited by DNA vaccination was also significantly enhanced with the mannan-liposome cocktail. This mannan-liposome-mediated activity was greatly inhibited by in vivo injection of anti-interferon (IFN)-gamma antibody, which suggests that IFN-gamma plays an important role in this HIV-specific immune response. The results of both isotype-specific antibody and cytokine analysis revealed that mannan-liposome-mediated DNA vaccination enhances Th1-mediated immunity.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9370932      PMCID： PMC1363989          DOI： 10.1046/j.1365-2567.1997.00307.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  Intracellular transport of MHC class II molecules.

Authors:  J J Neefjes; H L Ploegh
Journal:  Immunol Today       Date:  1992-05

2.  Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

Authors:  S Tamura; Y Samegai; H Kurata; T Nagamine; C Aizawa; T Kurata
Journal:  Vaccine       Date:  1988-10       Impact factor: 3.641

3.  Liposomes as carriers for intracellular delivery of nucleic acids.

Authors:  R M Straubinger; D Papahadjopoulos
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome.

Authors:  Y Noguchi; T Noguchi; T Sato; Y Yokoo; S Itoh; M Yoshida; T Yoshiki; K Akiyoshi; J Sunamoto; E Nakayama
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

5.  Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues.

Authors:  T Mizuochi; T J Matthews; M Kato; J Hamako; K Titani; J Solomon; T Feizi
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

6.  A novel cationic liposome reagent for efficient transfection of mammalian cells.

Authors:  X Gao; L Huang
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

7.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

8.  Structural analysis of glycosyl-phosphatidylinositol antigens of Leishmania major.

Authors:  G Rosen; P Påhlsson; M V Londner; M E Westerman; B Nilsson
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

9.  Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.

Authors:  M Corr; L F Boyd; S R Frankel; S Kozlowski; E A Padlan; D H Margulies
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells.

Authors:  R A Ezekowitz; K Sastry; P Bailly; A Warner
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307
View more
  21 in total

1.  Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.

Authors:  T Yoshida; K Okuda; K Q Xin; K Tadokoro; J Fukushima; S Toda; E Hagiwara; K Hamajima; T Koshino; T Saito
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.

Authors:  Marilyn E Ferrari; Denis Rusalov; Joel Enas; Carl J Wheeler
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

3.  Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.

Authors:  Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2003-12-02       Impact factor: 4.599

Review 4.  Recent advances in vaccine adjuvants.

Authors:  Manmohan Singh; Derek T O'Hagan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

Review 5.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 6.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

7.  Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.

Authors:  Yanwen Jin; Cheng Cao; Ping Li; Xuan Liu; Wei Huang; Chufang Li; Qingjun Ma
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

8.  Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity.

Authors:  M E Ferrari; D Rusalov; J Enas; C J Wheeler
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

9.  Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides.

Authors:  H Müller; G Mayer; B Behnke; E Heimüller; G Hamscher; D Immler; C Siethoff; H E Meyer; M Schreiber
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

10.  Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.

Authors:  Vincent W Bramwell; Jim E Eyles; Satyanarayana Somavarapu; H Oya Alpar
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.